Penumbra Inc 8-K, filed Dec 7, 2020
Penumbra Inc (PEN)
8-K
2020-12-07
For: 2020-12-07
View Original
Added on
April 12, 2026
About this 8-K
Penumbra Inc filed this 8-K on December 7, 2020.
Items reported
- Item 7.01: Regulation FD disclosure
__________________________________________________________________________________________________________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________________________________________________________________________________
FORM 8-K
_______________________________________________________________________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
_______________________________________________________________________________________________________________________________
(Exact name of registrant as specified in its charter)
_______________________________________________________________________________________________________________________________
| (State or other jurisdiction of incorporation or organization) | (Commission File No.) | (I.R.S. employer identification number) | ||||||
(Address of principal executive offices, including zip code)
(510 ) 748-3200
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
_______________________________________________________________________________________________________________________________
_______________________________________________________________________________________________________________________________
| Item 7.01. | Regulation FD Disclosure. | ||||
Penumbra, Inc. (the “Company”) is scheduled to participate in a CEO Discussion with Bank of America on Tuesday, December 8, 2020 at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time. During that event, the Company anticipates providing updates and information about its vascular and neuro businesses across a range of topics. An analyst note was published on December 6, 2020, with an inaccurate estimate of the percentage of the Company’s revenue for the fiscal quarter ended September 30, 2020 attributable to the Penumbra JET 7 Reperfusion Catheter with Xtra Flex technology (“JET 7 Xtra Flex”). JET 7 Xtra Flex represented 7.5% of the Company’s total revenue for such quarter. Additional information will be discussed during Tuesday’s event.
The information furnished on this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such a filing, except as expressly set forth by specific reference in such a filing. This report will not be deemed an admission as to the materiality of any information in the report that is required to be disclosed solely by Regulation FD.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Penumbra, Inc. | ||||||||
| Date: December 7, 2020 | By: | /s/ Maggie Yuen | ||||||
| Maggie Yuen | ||||||||
| Chief Financial Officer | ||||||||